InMed Pharmaceuticals Inc (INM)

1.40 -0.15  -9.68% NASDAQ Oct 15, 16:00 1.40 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All INM News

News

View All Events

Events

Date Type Description
11/15/2021 Earnings Results Q1 2022 Earnings Results
11/15/2021 11:30 EST Earnings Calls Q1 2022 Earnings Call
02/11/2021 Earnings Results Q2 2021 Earnings Results
02/11/2021 11:30 EST Earnings Calls Q2 2021 Earnings Call
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
  • URL: https://www.inmedpharma.com
  • Investor Relations URL: http://www.inmedpharma.com/s/stock-info.asp
  • HQ State/Province: British Columbia
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Nov. 15, 2021
  • Last Earnings Release: Feb. 11, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.